156 related articles for article (PubMed ID: 26191369)
1. Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.
Murray CW; Berdini V; Buck IM; Carr ME; Cleasby A; Coyle JE; Curry JE; Day JE; Day PJ; Hearn K; Iqbal A; Lee LY; Martins V; Mortenson PN; Munck JM; Page LW; Patel S; Roomans S; Smith K; Tamanini E; Saxty G
ACS Med Chem Lett; 2015 Jul; 6(7):798-803. PubMed ID: 26191369
[TBL] [Abstract][Full Text] [Related]
2. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
Canning P; Tan L; Chu K; Lee SW; Gray NS; Bullock AN
J Mol Biol; 2014 Jun; 426(13):2457-70. PubMed ID: 24768818
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.
Liu L; Hussain M; Luo J; Duan A; Chen C; Tu Z; Zhang J
Chem Biol Drug Des; 2017 Mar; 89(3):420-427. PubMed ID: 27589335
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
Kim HG; Tan L; Weisberg EL; Liu F; Canning P; Choi HG; Ezell SA; Wu H; Zhao Z; Wang J; Mandinova A; Griffin JD; Bullock AN; Liu Q; Lee SW; Gray NS
ACS Chem Biol; 2013 Oct; 8(10):2145-50. PubMed ID: 23899692
[TBL] [Abstract][Full Text] [Related]
5. Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors.
Gao M; Duan L; Luo J; Zhang L; Lu X; Zhang Y; Zhang Z; Tu Z; Xu Y; Ren X; Ding K
J Med Chem; 2013 Apr; 56(8):3281-95. PubMed ID: 23521020
[TBL] [Abstract][Full Text] [Related]
6. DDR1 and DDR2 physical interaction leads to signaling interconnection but with possible distinct functions.
Croissant C; Tuariihionoa A; Bacou M; Souleyreau W; Sala M; Henriet E; Bikfalvi A; Saltel F; Auguste P
Cell Adh Migr; 2018; 12(4):324-334. PubMed ID: 29616590
[TBL] [Abstract][Full Text] [Related]
7. Discoidin Domain Receptors: Potential Actors and Targets in Cancer.
Rammal H; Saby C; Magnien K; Van-Gulick L; Garnotel R; Buache E; El Btaouri H; Jeannesson P; Morjani H
Front Pharmacol; 2016; 7():55. PubMed ID: 27014069
[TBL] [Abstract][Full Text] [Related]
8. The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2.
Leitinger B; Steplewski A; Fertala A
J Mol Biol; 2004 Dec; 344(4):993-1003. PubMed ID: 15544808
[TBL] [Abstract][Full Text] [Related]
9. Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies.
El-Damasy AK; Kim HJ; Al-Karmalawy AA; Alnajjar R; Khalifa MM; Bang EK; Keum G
Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675389
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.
Toy KA; Valiathan RR; Núñez F; Kidwell KM; Gonzalez ME; Fridman R; Kleer CG
Breast Cancer Res Treat; 2015 Feb; 150(1):9-18. PubMed ID: 25667101
[TBL] [Abstract][Full Text] [Related]
11. Clustering, Spatial Distribution, and Phosphorylation of Discoidin Domain Receptors 1 and 2 in Response to Soluble Collagen I.
Yeung DA; Shanker N; Sohail A; Weiss BA; Wang C; Wellmerling J; Das S; Ganju RK; Miller JLC; Herr AB; Fridman R; Agarwal G
J Mol Biol; 2019 Jan; 431(2):368-390. PubMed ID: 30458172
[TBL] [Abstract][Full Text] [Related]
12. The discoidin domain receptor DDR2 is a receptor for type X collagen.
Leitinger B; Kwan AP
Matrix Biol; 2006 Aug; 25(6):355-64. PubMed ID: 16806867
[TBL] [Abstract][Full Text] [Related]
13. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer.
Elkamhawy A; Lu Q; Nada H; Woo J; Quan G; Lee K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207360
[TBL] [Abstract][Full Text] [Related]
14. Identification of type II and III DDR2 inhibitors.
Richters A; Nguyen HD; Phan T; Simard JR; Grütter C; Engel J; Rauh D
J Med Chem; 2014 May; 57(10):4252-62. PubMed ID: 24754677
[TBL] [Abstract][Full Text] [Related]
15. Collagen type I selectively activates ectodomain shedding of the discoidin domain receptor 1: involvement of Src tyrosine kinase.
Slack BE; Siniaia MS; Blusztajn JK
J Cell Biochem; 2006 Jun; 98(3):672-84. PubMed ID: 16440311
[TBL] [Abstract][Full Text] [Related]
16. Discoidin domain receptor (DDR) 1 and 2: collagen-activated tyrosine kinase receptors in the cornea.
Mohan RR; Mohan RR; Wilson SE
Exp Eye Res; 2001 Jan; 72(1):87-92. PubMed ID: 11133186
[TBL] [Abstract][Full Text] [Related]
17. Expression of discoidin domain receptor 1 tyrosine kinase on the human bronchial epithelium.
Sakamoto O; Suga M; Suda T; Ando M
Eur Respir J; 2001 May; 17(5):969-74. PubMed ID: 11488334
[TBL] [Abstract][Full Text] [Related]
18. A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases.
Iwata H; Oki H; Okada K; Takagi T; Tawada M; Miyazaki Y; Imamura S; Hori A; Lawson JD; Hixon MS; Kimura H; Miki H
ACS Med Chem Lett; 2012 Apr; 3(4):342-6. PubMed ID: 24900475
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2- a]pyrazin-3-ylethynyl)-4-isopropyl- N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2.
Wang Z; Zhang Y; Pinkas DM; Fox AE; Luo J; Huang H; Cui S; Xiang Q; Xu T; Xun Q; Zhu D; Tu Z; Ren X; Brekken RA; Bullock AN; Liang G; Ding K; Lu X
J Med Chem; 2018 Sep; 61(17):7977-7990. PubMed ID: 30075624
[TBL] [Abstract][Full Text] [Related]
20. The Regulation of Matrix Metalloproteinase Expression and the Role of Discoidin Domain Receptor 1/2 Signalling in Zoledronate-treated PC3 Cells.
Reel B; Korkmaz CG; Arun MZ; Yildirim G; Ogut D; Kaymak A; Micili SC; Ergur BU
J Cancer; 2015; 6(10):1020-9. PubMed ID: 26366216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
